| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JOCN.2006.03.023 |
| P698 | PubMed publication ID | 17532502 |
| P2093 | author name string | Ozkan Ates | |
| Suleyman R Cayli | |||
| Yusuf Turkoz | |||
| Ayhan Kocak | |||
| Ozcan Tarim | |||
| Celal O Cakir | |||
| Ilal Gurses | |||
| P433 | issue | 7 | |
| P304 | page(s) | 658-665 | |
| P577 | publication date | 2007-07-01 | |
| P1433 | published in | Journal of Clinical Neuroscience | Q6294963 |
| P1476 | title | Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury | |
| P478 | volume | 14 |
| Q36263581 | A Direct Comparison of Three Clinically Relevant Treatments in a Rat Model of Cervical Spinal Cord Injury |
| Q35127468 | A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury |
| Q36092501 | An overview of pharmacological approaches for management and repair of spinal cord injuries |
| Q62059921 | Autism throughout genetics: Perusal of the implication of ion channels |
| Q36345120 | Bridging the lesion-engineering a permissive substrate for nerve regeneration |
| Q35737505 | Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injury |
| Q83998860 | Curcumin Attenuates the Expression and Secretion of RANTES after Spinal Cord InjuryIn Vivoand Lipopolysaccharide-Induced Astrocyte ReactivationIn Vitro |
| Q33971965 | Dantrolene can reduce secondary damage after spinal cord injury |
| Q92890559 | Degenerative cervical myelopathy - update and future directions |
| Q51897460 | Dilantin Therapy in an Experimental Model of Traumatic Brain Injury: Effects of Limited versus Daily Treatment on Neurological and Behavioral Recovery |
| Q33972147 | Does dexmedetomidine reduce secondary damage after spinal cord injury? An experimental study |
| Q52727087 | Effect of Riluzole on Spinal Cord Regeneration with Hemisection Method Before Injury. |
| Q34713207 | Effect of neuroglobin genetically modified bone marrow mesenchymal stem cells transplantation on spinal cord injury in rabbits. |
| Q42031749 | Effect of neurosteroid modulation on global ischaemia-reperfusion-induced cerebral injury in mice |
| Q38223292 | Experimental trials in amyotrophic lateral sclerosis: a review of recently completed, ongoing and planned trials using existing and novel drugs |
| Q37851908 | Ion channel blockers and spinal cord injury |
| Q27004533 | Ion channels as drug targets in central nervous system disorders |
| Q37793800 | Kinin Receptor Antagonists as Potential Neuroprotective Agents in Central Nervous System Injury |
| Q41451579 | Left-shifted nav channels in injured bilayer: primary targets for neuroprotective nav antagonists? |
| Q39816346 | Membrane trauma and Na+ leak from Nav1.6 channels |
| Q33654943 | NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury |
| Q38435015 | Optogenetics applications for treating spinal cord injury |
| Q33805235 | Pathology dynamics predict spinal cord injury therapeutic success |
| Q37878593 | Pharmacological interventions for spinal cord injury: Where do we stand? How might we step forward? |
| Q47106198 | Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury |
| Q42914653 | Protective Effect of Combination of Sulforaphane and Riluzole on Glutamate-Mediated Excitotoxicity |
| Q57141481 | Riluzole Can Improve Sensory and Motor Function in Patients with Acute Spinal Cord Injury |
| Q38457735 | Riluzole as a neuroprotective drug for spinal cord injury: from bench to bedside. |
| Q38072212 | Riluzole for acute traumatic spinal cord injury: a promising neuroprotective treatment strategy |
| Q36983354 | Riluzole in psychiatry: a systematic review of the literature |
| Q34112946 | Riluzole protects against cardiac ischaemia and reperfusion damage via block of the persistent sodium current |
| Q53624330 | Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma |
| Q104567560 | Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial |
| Q38751614 | Sodium channels in astroglia and microglia |
| Q52683466 | Spinal cord injury pharmacotherapy: Current research & development and competitive commercial landscape as of 2015. |
| Q37833644 | Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages |
| Q24631225 | Spinal cord injury: a systematic review of current treatment options |
| Q36989202 | Spinal cord injury: time to move? |
| Q47836749 | Substance P as a Mediator of Neurogenic Inflammation after Balloon Compression Induced Spinal Cord Injury |
| Q90611855 | The Impact of Riluzole on Neurobehavioral Outcomes in Preclinical Models of Traumatic and Nontraumatic Spinal Cord Injury: Results From a Systematic Review of the Literature |
| Q37781898 | The Pathogenesis and Treatment of Acute Spinal Cord Injuries in Dogs |
| Q28748172 | The Persistent Sodium Current Blocker Riluzole Is Antiarrhythmic and Anti-Ischaemic in a Pig Model of Acute Myocardial Infarction |
| Q33602457 | The Sur1-Trpm4 Channel in Spinal Cord Injury |
| Q38112947 | Updates in the Management of the Small Animal Patient with Neurologic Trauma |
| Q30580969 | Voltage-gated sodium channel Nav 1.5 contributes to astrogliosis in an in vitro model of glial injury via reverse Na+ /Ca2+ exchange |
| Q87703317 | WITHDRAWN: Riluzole alleviates early neutrophil infiltration, brain oedema and lipid peroxidation in the traumatic brain tissue but does not induce neurotoxicity in non-traumatic brain tissue in rats |
Search more.